HFS
SPRY icon

Hughes Financial Services’s ARS Pharmaceuticals SPRY Stock Holding History

Hughes Financial Services’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8 Buy
+1
New +$9 ﹤0.01% 1820

Other funds holding SPRY

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
NFGCM
Norman Fields Gottscho Capital Management New York $330M AUM 27.75% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Hughes Financial Services's SPRY Position: Q2 2026 in Review

Hughes Financial Services opened a new position in ARS Pharmaceuticals (SPRY) in Q2 2026: 1 share worth $8. The stake represents ﹤0.01% of the portfolio and ranks #1820 among its holdings.

17 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

  • Hughes Financial Services held 1 share of ARS Pharmaceuticals worth $8 as of Q2 2026.
  • ARS Pharmaceuticals was a new Hughes Financial Services position in Q2 2026.
  • ARS Pharmaceuticals made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1820 holding.
  • 17 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.